Advertisement
Logo
Search for

Volume 149, Issue 5, Pages 752-761.e3 (May 2010)


View previous. 11 of 38 View next.

Four-Year Incidence and Progression of Diabetic Retinopathy and Macular Edema: The Los Angeles Latino Eye Study

Rohit VarmaabCorresponding Author Informationemail address, Farzana Choudhuryb, Ronald Kleinc, Jessica Chungb, Mina Torresab, Stanley P. Azenab, Los Angeles Latino Eye Study Group

Accepted 6 November 2009. published online 10 February 2010.

Purpose

To estimate the 4-year incidence and progression of diabetic retinopathy, macular edema (ME) and clinically significant macular edema (CSME) among adult Latinos with diabetes mellitus.

Design

A population-based, longitudinal study of 4658 self-identified Latinos (primarily Mexican Americans), residing in Los Angeles, examined at baseline (2000–2003) and at 4 years (2004–2008).

Methods

Participants underwent a standardized ophthalmic examination. Diabetic retinopathy (DR) and CSME were detected by grading of stereoscopic fundus photographs using the modified Airlie House classification scheme. χ2 and trend tests were used to assess differences in incidence when stratifying by age and duration of diabetes.

Results

The 4-year incidence of DR, ME, and CSME was 34.0% (182/535), 5.4% (38/699), and 7.2% (50/699) respectively. Younger persons and those with longer duration of diabetes mellitus had a higher incidence of DR compared to those who were older and had shorter duration of diabetes mellitus. A higher incidence of ME was associated with longer duration of diabetes mellitus (P = .004). Worsening/progression of any DR was found in 38.9% (126/324) and improvement occurred in 14.0% (37/265) of participants. Progression from nonproliferative DR (NPDR) to proliferative DR (PDR) and from NPDR to PDR with high-risk characteristics occurred in 5.3% and 1.9% of participants.

Conclusions

The 4-year incidence and progression of DR and the incidence of ME and CSME among Latinos are high compared to non-Hispanic whites. These findings support the need to identify and modify risk factors associated with these long-term complications.

a Doheny Eye Institute and Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California

b Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California

c Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin

Corresponding Author InformationInquiries to Rohit Varma, Doheny Eye Institute, Suite 4900, 1450 San Pablo St, Los Angeles, CA 90033

 Supplemental Material available at AJO.com.

PII: S0002-9394(09)00877-0

doi:10.1016/j.ajo.2009.11.014


View previous. 11 of 38 View next.

Advertisement